High-Throughput Sequencing Reveals CXCR4 and IGF1 Behave Different Roles in Weightlessness Osteoporosis

Dong Wang1,2, Weihang Li1, Ziyi Ding1

  • 1Department of Orthopedic Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.

Abstract

Insights

This study identifies key genes involved in weightlessness osteoporosis by analyzing gene expression in bone marrow mesenchymal stem cells under simulated microgravity. These findings offer insights into the molecular mechanisms and potential treatments for this condition.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Space medicine

Background:

  • Weightlessness osteoporosis is a significant health concern for astronauts.
  • Understanding the molecular mechanisms is crucial for developing countermeasures.
  • Bone marrow mesenchymal stem cells (BMSCs) play a vital role in bone health.

Purpose of the Study:

  • To screen differential mRNA expression profiles in BMSCs under simulated weightlessness.
  • To investigate the molecular pathogenesis of weightlessness osteoporosis.
  • To identify key genes and pathways involved in this process.

Main Methods:

  • Simulated microgravity (SMG) was applied to mouse BMSCs using a 2D-gyroscope.
  • High-throughput transcriptome sequencing was performed.
  • Bioinformatic analyses including differential gene expression (DEGs), Gene Ontology (GO), KEGG, GSEA, and protein-protein interaction (PPI) were utilized.

Main Results:

  • 263 differentially expressed genes (DEGs) were identified, with 186 upregulated and 77 downregulated.
  • DEGs were enriched in pathways related to osteoblast and osteoclast function, TNF signaling, and FoxO signaling.
  • Four hub genes (IL6, CXCR4, IGF1, PLOD2) were identified, contributing to the understanding of 10 significant genes in weightlessness osteoporosis.

Conclusions:

  • This study highlights the importance of 10 hub genes in the development of weightlessness osteoporosis.
  • The findings provide a theoretical foundation for further research into the pathogenesis and clinical treatment of weightlessness osteoporosis.
  • The identified molecular pathways offer potential targets for therapeutic interventions.

Related Concept Videos